Back to Search
Start Over
The impact of vaccination and patient characteristics on influenza vaccination uptake of elderly people : A discrete choice experiment
- Source :
- Vaccine, 36, 1467-1476, Vaccine, 36, 11, pp. 1467-1476, Vaccine, 36(11), 1467-1476. Elsevier, Vaccine, 36(11), 1467. Elsevier BV
- Publication Year :
- 2018
-
Abstract
- Contains fulltext : 188598.pdf (Publisher’s version ) (Open Access) Objectives: To improve information for patients and to facilitate a vaccination coverage that is in line with the EU and World Health Organization goals, we aimed to quantify how vaccination and patient characteristics impact on influenza vaccination uptake of elderly people. Methods: An online discrete choice experiment (DCE) was conducted among 1261 representatives of the Dutch general population aged 60 years or older. In the DCE, we used influenza vaccination scenarios based on five vaccination characteristics: effectiveness, risk of severe side effects, risk of mild side effects, protection duration, and absorption time. A heteroscedastic multinomial logit model was used, taking scale and preference heterogeneity (based on 19 patient characteristics) into account. Results: Vaccination and patient characteristics both contributed to explain influenza vaccination uptake. Assuming a base case respondent and a realistic vaccination scenario, the predicted uptake was 58%. One-way changes in vaccination characteristics and patient characteristics changed this uptake from 46% up to 61% and from 37% up to 95%, respectively. The strongest impact on vaccination uptake was whether the patient had been vaccinated last year, whether s/he had experienced vaccination side effects, and the patient’s general attitude towards vaccination. Conclusions: Although vaccination characteristics proved to influence influenza vaccination uptake, certain patient characteristics had an even higher impact on influenza vaccination uptake. Policy makers and general practitioners can use these insights to improve their communication plans and information regarding influenza vaccination for individuals aged 60 years or older. For instance, physicians should focus more on patients who had experienced side effects due to vaccination in the past, and policy makers should tailor the standard information folder to patients who had been vaccinated last year and to patient who had not. 10 p.
- Subjects :
- Male
Patient characteristics
Discrete choice experiment
Choice Behavior
0302 clinical medicine
Surveys and Questionnaires
Outcome Assessment, Health Care
80 and over
Medicine
Elderly people
vaccination characteristics
030212 general & internal medicine
Non-U.S. Gov't
patient characteristics
Multinomial logistic regression
Aged, 80 and over
education.field_of_study
030503 health policy & services
Research Support, Non-U.S. Gov't
Vaccination
Age Factors
Middle Aged
influenza vaccination
Infectious Diseases
Influenza Vaccines
Vaccination coverage
Respondent
Molecular Medicine
Female
Public Health
0305 other medical science
Human
Population
Research Support
vaccination uptake
03 medical and health sciences
Outcome Assessment (Health Care)
SDG 3 - Good Health and Well-being
Immunology and Microbiology(all)
Influenza, Human
Journal Article
Humans
education
Geriatric Assessment
Aged
General Veterinary
General Immunology and Microbiology
business.industry
discrete choice experiment
Environmental and Occupational Health
Public Health, Environmental and Occupational Health
Patient Acceptance of Health Care
veterinary(all)
Influenza
Socioeconomic Factors
business
Developmental Psychopathology
Demography
Subjects
Details
- Language :
- English
- ISSN :
- 14671476 and 0264410X
- Database :
- OpenAIRE
- Journal :
- Vaccine, 36, 1467-1476, Vaccine, 36, 11, pp. 1467-1476, Vaccine, 36(11), 1467-1476. Elsevier, Vaccine, 36(11), 1467. Elsevier BV
- Accession number :
- edsair.doi.dedup.....81a57722f9227d634cd515fe75015e1c